£1.61m
+437%vs Apr 2024From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Cyanocapture Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CYANOCAPTURE LTD is an active private limited company (company number 13307428) incorporated on 1 April 2021, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2025, showing net assets of £1.61m and cash of £1.44m, with 15 employees on average. Net assets rose 437% on the prior period (£299k).
Peer position · net assets
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Mr David Kim
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Mr Samir Chitnavis
- owns 25–50% of shares
- holds 25–50% of voting rights
- Miss Laura Martin
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 1 April 20215 yrs ago
- Next accounts due
- 30 January 2027in 99 days
- Confirmation statement due
- 15 April 2027in 174 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.44m
+630%vs Apr 2024Not reported
15
+15%vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £1.61m | £1.44m | £108k | — | — | — | 15 |
| 30 April 2024 | £299k | £198k | £100k | — | — | — | 13 |
Cash per employee£96kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,607,639 at 30 April 2025
- Net assets up 10% or more on the prior period+437.4% vs prior period
- Cash at bank of £50,000 or moreCash £1,443,593
- Incorporated five or more years agoIncorporated 1 April 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 174 days
- Next accounts duein 99 days
- Accounts period endNet assets £1.61m · small accounts
- Accounts period endNet assets £299k · small accounts
- Incorporated
08
Similar companies in Oxford
- SYNOX THERAPEUTICS UK LIMITEDOxford · inc. Apr 2021
- SYNAPTIXBIO LTDOxford · inc. Apr 2021
- LUCA SCIENCE U.K. LTDOxford · inc. Mar 2021
- WILD BIOSCIENCE LTDAbingdon · inc. Apr 2021
- MITORX THERAPEUTICS LIMITEDOxford · inc. Mar 2021
- BLUE EARTH THERAPEUTICS LIMITEDOxford · inc. Feb 2021
All companies incorporated on 1 April 2021 · in Apr 2021.
09
Reminders for CYANOCAPTURE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.